The Burrill Report
The Burrill Report (April 4, 2011): Getting Back on Track (.MP3,11.95 Mb)
Cynapsus Therapeutics is a small Canadian specialty pharma trying to reinvent itself. Under Anthony Giovinazzo, who took the helm at the end of 2009, the company has a new name and new focus. It’s hoping that its reformulation of an existing treatment for Parkinson’s disease can put it on a fast path to revenue with limited investment. We spoke to Giovinazzo about the company’s strategy, the advantages of its reformulated version of the long-standing drug apomorphine, and what lessons can be drawn from the company’s approach.
April 01, 2011
http://www.burrillreport.com/article-getting_back_on_track.html